slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 94,261-94,290
Pages 3,953
Rows per page 30
Component
94,261-94,290 of 118,578
19
Includes a list of notable signings and associated high-profile artists.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
21
Uses a visual diagram to show the divergence between revenue and expenses over time.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
31
The slide highlights the cost structure differences between publishing and recorded music, leading to a concluding statement about operating leverage.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
35
Reservoir | Investor Presentation Deck | 35 slidesReservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
03
Roivant Sciences | Investor Presentation Deck | 21 slidesRoivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
12
Includes financial runway disclosure in the footer.Roivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
01
Includes exhibit number and presenter credentials.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
03
SAB Biotherapeutics | Results Presentation Deck | 12 slidesSAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
05
The table uses color coding to distinguish between vaccine strains (green) and non-vaccine strains (blue).SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
10
The chart shows a clear separation between the treatment and placebo groups, indicating faster viral clearance in the treatment arm.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
11
SAB Biotherapeutics | Results Presentation Deck | 12 slidesSAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
01
Salvatore Ferragamo | Results Presentation Deck | 13 slidesSalvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · Attention1 hit
07
Includes a highlight box around the 2022 column. Data is in Euro MM.Salvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
Salvatore Ferragamo | Results Presentation Deck | 13 slidesSalvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · Action1 hit
02
The slide highlights the impact of crypto market volatility on digital asset deposits versus growth in other banking divisions.Signature Bank | Results Presentation Deck | 3 slides · Signature Bank
Conference presentation Investor relations Beat · Interest1 hit
01
Skillsoft | Results Presentation Deck | 14 slidesSkillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations Beat · Attention1 hit
05
The table uses a waterfall-style logic to explain the variance between previous and updated outlooks.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
06
Includes notes on fiscal year end, product level view, and Codecademy inclusion.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations Beat · What Is1 hit
07
Proforma values include Codecademy starting April 5th of each year. Fiscal years end January 31.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations Beat · What Is1 hit
01
The slide features a high-quality photograph of an aircraft hangar facility.SkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations 1 hit
01
Exhibit 99.2 identifier present.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit
10
Includes longitudinal CT scan imagery and a line chart tracking tumor diameter and volume reduction.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
25
Patients with baseline levels of SMRP in normal range were excluded. Data cutoff: September 9, 2022.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
30
The chart shows the breakdown of patient eligibility by MSLN expression levels (50%, 2+/3+ vs 50%, 1+ vs Not eligible).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
31
The chart is a swimmer plot showing patient response over time, including redosing events and disease progression.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
32
Uses multiparameter immunofluorescence to visualize tumor markers (PanCK), T cells (CD3), TAMs (CD68), and inhibitory ligands (CD155, PD-L1).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
01
Third Harmonic Bio | IPO Presentation Deck | 24 slidesThird Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank 1 hit
06
The data highlights the mechanism of action of KIT inhibition (inactivation and depletion) supported by Phase 1b interim results.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
09
The chart displays multiple dose cohorts (200mg QD, 200mg BID, 400mg BID, 500mg QD FED) with error bars representing standard deviation.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
16
The slide uses clinical data to justify a new indication for a drug candidate by highlighting the role of mast cells in asthma pathophysiology.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit